The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Value Is Expected For The Intranasal Corticosteroids Market At The End Of The 2026–2030 Forecast Period?
The market for intranasal corticosteroids has experienced significant growth in recent years. It is anticipated to expand from $6.78 billion in 2025 to $7.31 billion in 2026, progressing at a compound annual growth rate (CAGR) of 7.8%. Historically, this growth was influenced by factors including limited awareness of intranasal corticosteroids, reliance on hospital pharmacies for drug distribution, a growing incidence of nasal allergies, a preference for conventional treatment methods, and restricted online pharmacy access.
The market for intranasal corticosteroids is anticipated to experience substantial expansion over the upcoming years. Its value is projected to reach $9.74 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.4%. This anticipated growth during the forecast period stems from factors such as heightened healthcare awareness, the expansion of retail and online pharmacies, an increase in the occurrence of chronic rhinitis and nasal polyps, the integration of combination therapies, and the creation of user-friendly spray devices. Key trends identified for this period encompass a growing prevalence of allergic rhinitis and various nasal disorders, a greater uptake of prescription intranasal corticosteroids, an increase in the utilization of over-the-counter intranasal corticosteroids, the broadening of hospital and homecare distribution channels, and an emphasis on patient-centered treatment coupled with ease of administration.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25799&type=smp
What Major Growth Drivers Are Shaping The Outlook Of The Intranasal Corticosteroids Market?
The rising incidence of allergic rhinitis is anticipated to boost the growth of the intranasal corticosteroids market going forward. Allergic rhinitis constitutes an allergic reaction that results in inflammation of the nasal passages, commonly triggered by airborne allergens such as pollen, dust mites, mold, or pet dander. The expanding prevalence of allergic rhinitis primarily stems from increasing environmental pollution, which exposes individuals to airborne allergens and irritants that initiate allergic responses in the nasal passages. Intranasal corticosteroids facilitate the management of allergic rhinitis by reducing inflammation in the nasal passages, thereby alleviating symptoms like sneezing, congestion, and a runny nose. For instance, in October 2023, according to the National Library of Medicine, a US-based biomedical library, allergic rhinitis affects more than 400 million people worldwide, with prevalence rates estimated at 10% to 30% among adults and over 40% in children. Thus, the growing prevalence of allergic rhinitis is driving the intranasal corticosteroid market.
What Segment Types Make Up The Intranasal Corticosteroids Market?
The intranasal corticosteroids market covered in this report is segmented –
1) By Drug Types: Prescribed Drugs, Over-The-Counter Drugs
2) By Application: Allergic Rhinitis, Nasal Polyps, Sinusitis, Other Applications
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channel
4) By End User: Hospitals, Clinics, Homecare, Healthcare Providers
Subsegments:
1) By Prescribed Drugs: Fluticasone Propionate, Mometasone Furoate, Budesonide, Beclomethasone Dipropionate, Ciclesonide
2) By Over-The-Counter Drugs: Triamcinolone Acetonide, Fluticasone Furoate, Budesonide Over-The-Counter Drugs
Which Market Trends Are Creating New Opportunities In The Intranasal Corticosteroids Market?
Key companies in the intranasal corticosteroids market are concentrating on developing innovative formulations, such as nasal sprays, to improve targeted delivery and patient adherence. Nasal sprays are fluid medications administered directly into the nose using a spray nozzle to address conditions like allergies, congestion, or inflammation. They facilitate quick drug absorption via the nasal mucosa, offering rapid relief with minimal systemic impact. For example, in March 2024, OptiNose Inc., a US-based pharmaceutical company, secured approval from the U.S. Food and Drug Administration (FDA) for XHANCE, which is the first and only treatment specifically indicated for adults suffering from chronic rhinosinusitis (CRS) without nasal polyps. This nasal spray utilizes a unique exhalation delivery system that allows the medication to reach deep into the nasal cavity, effectively managing CRS in adults, whether or not nasal polyps are present. Each spray dispenses 93 mcg of fluticasone propionate, and the device is operated by the user blowing into a mouthpiece while simultaneously activating the spray into the nostril, ensuring accurate delivery and enhanced symptom alleviation.
Who Are The Key Players Driving Competition In The Intranasal Corticosteroids Market?
Major companies operating in the intranasal corticosteroids market are GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Sandoz Group AG, Haleon plc, Intas Pharmaceuticals Limited, Organon Pharma (UK) Limited, Sun Pharmaceutical Industries Ltd., Apotex Inc., Perrigo Company plc, Aurobindo Pharma Limited, Cipla Ltd., Hikma Pharmaceuticals plc, Zydus Lifesciences Ltd., Glenmark Pharmaceuticals Limited, OptiNose US Inc., Taro Pharmaceutical Industries Ltd., Maya Biotech Private Limited, AdvaCare Pharma USA, Lupin Ltd., Xenone Healthcare Private Limited.
Read the full intranasal corticosteroids market report here:
https://www.thebusinessresearchcompany.com/report/intranasal-corticosteroids-global-market-report
Which Regions Are Projected To Dominate The Intranasal Corticosteroids Market In The Coming Years?
North America was the largest region in the intranasal corticosteroids market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intranasal corticosteroids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Intranasal Corticosteroids Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=25799&type=smp
Browse Through More Reports Similar to the Global Intranasal Corticosteroids Market 2026, By The Business Research Company
Internal Nasal Dilators Market Report 2026
https://www.thebusinessresearchcompany.com/report/internal-nasal-dilators-global-market-report
Corticosteroid Market Report 2026
https://www.thebusinessresearchcompany.com/report/corticosteroid-global-market-report
Intranasal Drug Delivery Devices Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model